{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "CD4",
      "SARS-CoV-2",
      "T cells",
      "common cold coronaviruses",
      "immune memory",
      "longitudinal analysis",
      "steady state"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35932763",
  "DateCompleted": {
    "Year": "2022",
    "Month": "09",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "07",
        "Day": "20"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.chom.2022.07.012",
      "S1931-3128(22)00358-4"
    ],
    "Journal": {
      "ISSN": "1934-6069",
      "JournalIssue": {
        "Volume": "30",
        "Issue": "9",
        "PubDate": {
          "Year": "2022",
          "Month": "Sep",
          "Day": "14"
        }
      },
      "Title": "Cell host & microbe",
      "ISOAbbreviation": "Cell Host Microbe"
    },
    "ArticleTitle": "Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic.",
    "Pagination": {
      "StartPage": "1269",
      "EndPage": "1278.e4",
      "MedlinePgn": "1269-1278.e4"
    },
    "Abstract": {
      "AbstractText": [
        "The immune memory to common cold coronaviruses (CCCs) influences SARS-CoV-2 infection outcome, and understanding its effect is crucial for pan-coronavirus vaccine development. We performed a longitudinal analysis of pre-COVID19-pandemic samples from 2016-2019 in young adults and assessed CCC-specific CD4+ T\u00a0cell and antibody responses. Notably, CCC responses were commonly detected with comparable frequencies as with other common antigens and were sustained over time. CCC-specific CD4+ T\u00a0cell responses were associated with low HLA-DR+CD38+ signals, and their magnitude did not correlate with yearly CCC infection prevalence. Similarly, CCC-specific and spike RBD-specific IgG responses were stable in time. Finally, high CCC-specific CD4+ T\u00a0cell reactivity, but not antibody titers, was associated with pre-existing SARS-CoV-2 immunity. These results provide a valuable reference for understanding the immune response to endemic coronaviruses and suggest that steady and sustained CCC responses are likely from a stable pool of memory CD4+ T\u00a0cells due to repeated earlier exposures and possibly occasional reinfections."
      ],
      "CopyrightInformation": "Copyright \u00a9 2022 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA."
          }
        ],
        "LastName": "Yu",
        "ForeName": "Esther Dawen",
        "Initials": "ED"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7290, USA."
          }
        ],
        "LastName": "Narowski",
        "ForeName": "Tara M",
        "Initials": "TM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Eric",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA."
          }
        ],
        "LastName": "Garrigan",
        "ForeName": "Emily",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA."
          }
        ],
        "LastName": "Mateus",
        "ForeName": "Jose",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA."
          }
        ],
        "LastName": "Frazier",
        "ForeName": "April",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA."
          }
        ],
        "LastName": "Weiskopf",
        "ForeName": "Daniela",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA."
          }
        ],
        "LastName": "Grifoni",
        "ForeName": "Alba",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7290, USA."
          }
        ],
        "LastName": "Premkumar",
        "ForeName": "Lakshmanane",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA. Electronic address: rantunes@lji.org."
          }
        ],
        "LastName": "da Silva Antunes",
        "ForeName": "Ricardo",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA. Electronic address: alex@lji.org."
          }
        ],
        "LastName": "Sette",
        "ForeName": "Alessandro",
        "Initials": "A"
      }
    ],
    "GrantList": [
      {
        "GrantID": "75N93019C00065",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U01 AI141995",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U19 AI142742",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U54 CA260543",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cell Host Microbe",
    "NlmUniqueID": "101302316",
    "ISSNLinking": "1931-3128"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunoglobulin G"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "bioRxiv. 2022 Mar 02;:",
      "PMID": "35262082"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunoglobulin G"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunologic Memory"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    }
  ],
  "CoiStatement": "Declaration of interests A.S. is a consultant for Gritstone Bio, Flow Pharma, Arcturus Therapeutics, ImmunoScape, CellCarta, Avalia, Moderna, Fortress, and Repertoire. L.J.I. has filed for patent protection for various aspects of the SARS-CoV-2 epitope pools design."
}